Literature DB >> 9673558

Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer.

K Kurozumi1, T Nishida, K Nakao, M Nakahara, M Tsujimoto.   

Abstract

Lymph node metastasis is a critical prognostic factor for gastric cancer. In the present investigation we examined clinicopathologic factors influencing the metastatic processes to the lymph mode and their prognostic importance. A randomly selected group of 98 patients with adenocarcinomas of the stomach who underwent gastrectomy plus systematic lymph node dissection at Osaka Police Hospital from 1991 to 1996 were analyzed. Altogether 37 (38%) cancers were positive for CD44 variant 6 (v6) staining, 31 (32%) were intermediately stained, and 30 (30%) were negative. CD44-v6 expression correlated well with lymph node metastasis. Expression of CD44-v6 and lymphatic invasion were independent risk factors for metastatic lymph nodes. Among the patients with CD44-v6-positive and lymphatic invasion-positive cancers, 88% had lymph node metastasis, whereas only 13% of patients negative for both factors had lymph node metastasis. Although CD44-v6 expression and lymphatic invasion have been reported to be risk factors for recurrence and a poor prognosis, in this investigation these factors were found not to be significant for hematogenous and lymphatic recurrences or overall survival rates. Thus expression of CD44-v6 and lymphatic invasion may regulate lymph node metastases from gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673558     DOI: 10.1007/s002689900481

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma.

Authors:  T Nozoe; S Kohnoe; T Ezaki; A Kabashima; Y Maehara
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-11       Impact factor: 4.553

2.  Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis.

Authors:  Wei Wang; Li-Ping Dong; Ning Zhang; Cheng-Hai Zhao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

Review 4.  Gastric cancer stem cells: evidence, potential markers, and clinical implications.

Authors:  Daniel Brungs; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Martin G Carolan; Marie Ranson
Journal:  J Gastroenterol       Date:  2015-10-01       Impact factor: 7.527

5.  Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers.

Authors:  Heike Immervoll; Dag Hoem; Ole Johnny Steffensen; Hrvoje Miletic; Anders Molven
Journal:  J Histochem Cytochem       Date:  2011-04       Impact factor: 2.479

6.  Impact of structurally modifying hyaluronic acid on CD44 interaction.

Authors:  D Bhattacharya; D Svechkarev; J J Souchek; T K Hill; M A Taylor; A Natarajan; A M Mohs
Journal:  J Mater Chem B       Date:  2017-09-20       Impact factor: 6.331

7.  Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer.

Authors:  Bang Wool Eom; Keun Won Ryu; Hong Man Yoon; Myeong-Cherl Kook
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

8.  The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.

Authors:  Ying Wu; Weiwei Wang; Yinting Chen; Kaihong Huang; Xintao Shuai; Qikui Chen; Xuexian Li; Guoda Lian
Journal:  Int J Nanomedicine       Date:  2010-03-09

9.  Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.

Authors:  Suniti Misra; Vincent C Hascall; Carla De Giovanni; Roger R Markwald; Shibnath Ghatak
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

Review 10.  Progress on RNAi-based molecular medicines.

Authors:  Jing Chen; Jianping Xie
Journal:  Int J Nanomedicine       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.